Does LEDIPASVIR\SOFOSBUVIR Cause Interstitial lung disease? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Interstitial lung disease have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.2% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
35
Reports of Interstitial lung disease with LEDIPASVIR\SOFOSBUVIR
0.2%
of all LEDIPASVIR\SOFOSBUVIR reports
7
Deaths
18
Hospitalizations
How Dangerous Is Interstitial lung disease From LEDIPASVIR\SOFOSBUVIR?
Of the 35 reports, 7 (20.0%) resulted in death, 18 (51.4%) required hospitalization, and 5 (14.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Hepatocellular carcinoma (640)
Vomiting (623)
Dizziness (604)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Interstitial lung disease Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB